VENUSREM VENUS REMEDIES LTD.
Healthcare
LTP
1,231.75
CHG · %
-47.5 (-3.71%)
VOL · TODAY
48.13K
PREV CLOSE
1,279.25
Today's range1,230 · 1,315.95
1,231.75
52-week range432.1 · 2,044.3
1,231.75
Loading candles…
Venus Remedies Ltd, incorporated in 1989, is a research-based pharmaceutical company operating in the pharmaceutical and healthcare industries. The company focuses on developing and manufacturing therapeutic solutions primarily within critical care segments, including treatments for multi-drug resistant bacteria. Its product portfolio spans anti-infectives such as antibiotics, oncology, neurology, pain management, and skin and wound care. Venus Remedies serves both domestic and international markets through its manufacturing facilities. The company includes the Venus Medicine Research Centre (VMRC), its research division accredited by the Department of Scientific and Industrial Research (DSIR). No information on founders, key management, listings, or notable projects was provided.
VENUSREM is not part of any active scan today.
This page is a live market overview for VENUS REMEDIES LTD. (VENUSREM) on the BSE. As a listed security, VENUS REMEDIES LTD. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for VENUSREM before placing trades on tick2trade.
As of the latest feed, VENUSREM last traded at ₹1,231.75 on BSE, down ₹47.5 (3.71%) from the previous close of ₹1,279.25. Today's session range is ₹1,230 – ₹1,315.95, against a 52-week band of ₹432.1 – ₹2,044.3. Traded volume today stands at 48.13K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for VENUSREM in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether VENUSREM is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for VENUS REMEDIES LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in VENUSREM. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated VENUSREM option chain page linked from this overview.
// similar in healthcare326 total